Cocrystal PharmaCOCP
13F holders, Q2 2024 (June 30)14holders −2
1new positions
3sold out
1famous investor
$2.33avg. 13F price*
At the end of Q2 2024, 14 institutions reported holding Cocrystal Pharma Inc. (COCP) in their 13F filings, down 2 from Q1 2024. 1 opened new positions and 3 sold out. The largest holders were Vanguard Group Inc. ($642K), Renaissance Technologies ($302K) and BlackRock Inc. ($172K). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Cocrystal Pharma Inc.
- CUSIP
- 19188J409
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2 |
| Exits | 3 | $29K |
All 13F filers, Q1 2024 → Q2 2024: 8,288 shares bought and 55,486 shares sold, net −47,198 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Vanguard Group Inc. | 0.00% | No change | 275,656 | $642K |
| Renaissance Technologies | 0.00% | Add +3.0% | 129,828 | $302K |
| BlackRock Inc. | 0.00% | No change | 73,746 | $172K |
| Geode Capital Management, LLC | 0.00% | Add +7.3% | 64,832 | $151K |
| Morgan Stanley | 0.00% | Add +0.1% | 59,300 | $138K |
| Susquehanna International Group, LLP | 0.00% | Reduce -51.9% | 25,052 | $58K |
| State Street Corp. | 0.00% | Reduce -16.0% | 20,543 | $48K |
| Northern Trust Corp. | 0.00% | Reduce -0.3% | 12,171 | $28K |
| Bank of America Corp. | 0.00% | Add +0.7% | 9,033 | $21K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -50.6% | 3,681 | $9K |
| JPMorgan Chase & Co. | 0.00% | Reduce -21.2% | 428 | $997 |
| Nvwm, LLC | 0.00% | No change | 84 | $196 |
| Activest Wealth Management | 0.00% | New | 1 | $2 |
| Royal Bank of Canada | 0.00% | No change | 51 | $0 |
"% of holder's portfolio" is COCP's weight in each manager's 13F, not the share of Cocrystal Pharma Inc. the manager owns.